A Clinical and Economic Comparison of Cell-Based Versus Recombinant Influenza Vaccines in Adults 18-64 Years in the United States.
Levin MJ, Rawashdh NA, Mofor L, Anaya P, Zur RM, Kahn EB, Yu D, Mould-Quevedo JF. A Clinical and Economic Comparison of Cell-Based Versus Recombinant Influenza Vaccines in Adults 18-64 Years in the United States. Vaccines (Basel). 2024 Oct 26; 12(11).